Genus (LON:GNS) Insider Sells £78,211.50 in Stock

Genus plc (LON:GNS – Get Free Report) insider Jorgen Kokke sold 3,450 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of GBX 2,267, for a total value of £78,211.50.

Genus Trading Down 0.5%

GNS stock traded down GBX 12 during trading on Wednesday, hitting GBX 2,260. The company had a trading volume of 59,055 shares, compared to its average volume of 756,529. Genus plc has a 52-week low of GBX 1,890 and a 52-week high of GBX 3,220. The company has a 50 day simple moving average of GBX 2,542.80 and a 200-day simple moving average of GBX 2,640.41. The firm has a market capitalization of £1.50 billion, a P/E ratio of 31.83, a PEG ratio of 2.87 and a beta of 0.90. The company has a quick ratio of 1.08, a current ratio of 2.25 and a debt-to-equity ratio of 55.10.

Get Genus alerts:

Genus (LON:GNS – Get Free Report) last released its quarterly earnings data on Thursday, February 26th. The company reported GBX 60.80 earnings per share (EPS) for the quarter. Genus had a net margin of 7.07% and a return on equity of 9.70%. As a group, research analysts forecast that Genus plc will post 70.9644323 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Berenberg Bank restated a “buy” rating and issued a GBX 3,350 price objective on shares of Genus in a report on Monday. Shore Capital Group restated a “buy” rating and set a GBX 3,000 price target on shares of Genus in a research report on Friday, January 16th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Genus from GBX 3,100 to GBX 3,300 and gave the company a “buy” rating in a report on Friday, January 16th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of GBX 3,216.67.

Get Our Latest Analysis on Genus

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.

Read More

• Five stocks we like better than Genus
• Dream Finders Homes’ Hostile Bid Creates a Dual Squeeze Play
• Why OpenAI’s IPO Plans Could Be a Massive Win for Microsoft
• A Real Biggie Deal: Wendy’s Serves Up a Juicy Buyout Arbitrage
• Ally Financial Is Back to Basics—And Investors Are Watching

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.